Unspecified Childhood Solid Tumor, Protocol Specific [clinicaltrials_resource:4e42afc1e73febcbe5daced0fe655385]
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer [clinicaltrials:NCT00002485]Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors [clinicaltrials:NCT00002543]Interferon Alfa in Treating Children With HIV-Related Cancer [clinicaltrials:NCT00002621]clinicaltrials:NCT00002663Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer [clinicaltrials:NCT00003070]Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors [clinicaltrials:NCT00003073]High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors [clinicaltrials:NCT00003173]Fenretinide in Treating Children With Solid Tumors [clinicaltrials:NCT00003191]Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors [clinicaltrials:NCT00003194]Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors [clinicaltrials:NCT00003288]Irofulven in Treating Children With Recurrent or Refractory Solid Tumors [clinicaltrials:NCT00003370]Arsenic Trioxide in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00003630]clinicaltrials:NCT00003739clinicaltrials:NCT00003750Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers [clinicaltrials:NCT00003754]Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count [clinicaltrials:NCT00003805]clinicaltrials:NCT00003816Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant [clinicaltrials:NCT00003894]Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation [clinicaltrials:NCT00003898]Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin [clinicaltrials:NCT00004005]Irinotecan in Treating Children With Refractory Solid Tumors [clinicaltrials:NCT00004078]DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas [clinicaltrials:NCT00004212]Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy [clinicaltrials:NCT00004919]Gemcitabine in Treating Children With Refractory Solid Tumors [clinicaltrials:NCT00005577]Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment [clinicaltrials:NCT00005811]Oxaliplatin in Treating Children With Advanced Solid Tumors [clinicaltrials:NCT00005844]Quality of Life in Children Treated for Cancer [clinicaltrials:NCT00005881]BMS-214662 in Treating Patients With Solid Tumors [clinicaltrials:NCT00005973]Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy [clinicaltrials:NCT00006095]Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00006102]clinicaltrials:NCT00006348Ecteinascidin 743 in Treating Children With Refractory Solid Tumors [clinicaltrials:NCT00006463]Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants [clinicaltrials:NCT00008424]Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas [clinicaltrials:NCT00012181]Irinotecan in Treating Children With Refractory or Progressive Solid Tumors [clinicaltrials:NCT00016861]Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate [clinicaltrials:NCT00018967]Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors [clinicaltrials:NCT00020150]Bortezomib in Treating Children With Advanced Solid Tumors [clinicaltrials:NCT00021216]Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors [clinicaltrials:NCT00024284]Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma [clinicaltrials:NCT00027937]
condition [clinicaltrials_vocabulary:condition]
Unspecified Childhood Solid Tumor, Protocol Specific [clinicaltrials_resource:4e42afc1e73febcbe5daced0fe655385]
Bio2RDF identifier
4e42afc1e73febcbe5daced0fe655385
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4e42afc1e73febcbe5daced0fe655385
identifier
clinicaltrials_resource:4e42afc1e73febcbe5daced0fe655385
title
Unspecified Childhood Solid Tumor, Protocol Specific
@en
label
Unspecified Childhood Solid Tu ...... 2afc1e73febcbe5daced0fe655385]
@en